Conditions & diseases

interstitial lung disease

Observed in 154 articles across 12 journals.

Falling

Latest share0.39%

Change vs baseline-0.28 pp

Months observed12

Latest monthJul 2026

Portfolio article share

Attention over this snapshot

13 monthly points

Journal breadth

Where it appears

Journal of Scleroderma and Related Disorders56
Thorax39
BMJ Open Respiratory Research23
RMD Open11
BMJ Open7
BMJ Case Reports6
European Journal of Hospital Pharmacy4
BMJ Supportive & Palliative Care2
Lupus Science & Medicine2
Occupational and Environmental Medicine2
Drug and Therapeutics Bulletin1
Emergency Medicine Journal1

Co-occurrence

Explore nearby topics

Inspect the source signal

Article evidence

30 high-ranking examples

RMD Open · 2026-07-15

Evaluation of the prognostic value of visual and quantitative CT analysis in myositis-associated interstitial lung disease

Phrase rank #1 · DOI 10.1136/rmdopen-2026-006869

BMJ Open Respiratory Research · 2026-07-01

P15 Neutral ground? The clinical impact of race-neutral spirometry in interstitial lung disease

Phrase rank #1 · DOI 10.1136/bmjresp-2026-artp.17

Journal of Scleroderma and Related Disorders · 2026-06-16

Lung ultrasound (LUS) for screening systemic sclerosis-associated interstitial lung disease (SSc-ILD): a radiation-free alternative?

Phrase rank #1 · DOI 10.1136/jsrd-2026-000013

BMJ Open Respiratory Research · 2026-06-09

Protocol for the INterstitial lung Disease EXacerbations (INDEX) Study: a retrospective multicentre cohort study

Phrase rank #1 · DOI 10.1136/bmjresp-2025-003949

Journal of Scleroderma and Related Disorders · 2026-06-05

P.103 Interstitial lung disease in systemic autoimmune rheumatic diseases: radiologic and histologic correlations

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.153

Journal of Scleroderma and Related Disorders · 2026-06-05

P.121 Evaluation of the living with pulmonary fibrosis questionnaire in patients with systemic sclerosis associated interstitial lung disease: monocentric Results

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.171

Journal of Scleroderma and Related Disorders · 2026-06-05

P.109 Prognostic value of quantitative chest computed tomography for predicting progression of mild interstitial lung disease in systemic sclerosis: a multicentric nested case-control study

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.159

Journal of Scleroderma and Related Disorders · 2026-06-05

P.093 Association TH serum level of IL-13 with interstitial lung disease in systemic sclerosis patients

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.144

Journal of Scleroderma and Related Disorders · 2026-06-05

P.108 Predicting progression of mild interstitial lung disease in systemic sclerosis: an international retrospective cohort study

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.158

Journal of Scleroderma and Related Disorders · 2026-06-05

P.113 Heterogeneity in treatment outcomes for systemic sclerosis with or without interstitial lung disease: a systematic literature review

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.163

Journal of Scleroderma and Related Disorders · 2026-06-05

P.028 Interleukin-19 is related to systemic sclerosis, especially interstitial lung disease

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.81

Journal of Scleroderma and Related Disorders · 2026-06-05

P.112 Interstitial lung disease in systemic sclerosis: clinical, serological, and instrumental associations in a Ukrainian patient cohort

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.162

Journal of Scleroderma and Related Disorders · 2026-06-05

P.098 Pulmonary microbiome in patients with interstitial lung disease secondary to scleroderma and other connective tissue diseases: a pilot study project funded by PNRR – nextgenerationeu PNRR-MCNT2-2023-1

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.148

Journal of Scleroderma and Related Disorders · 2026-06-05

P.401 The prevalence of interstitial lung disease in diagnosed cases of rheumatoid arthritis in tertiary care center

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.442

Journal of Scleroderma and Related Disorders · 2026-06-05

P.090 Deep-learning analysis of HRCT images predicts progression and mortality in systemic sclerosis related interstitial lung disease

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.141

Journal of Scleroderma and Related Disorders · 2026-06-05

P.111 Association of systemic sclerosis-related interstitial lung disease with tumor-associated antigens and their autoantibodies

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.161

Journal of Scleroderma and Related Disorders · 2026-06-05

P.094 Clinical characteristics of systemic sclerosis with interstitial lung disease, one center experience

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.145

Journal of Scleroderma and Related Disorders · 2026-06-05

P.104 Nintedanib in systemic sclerosis-associated interstitial lung disease: real-world multicenter cohort study on tolerability and discontinuation

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.154

Journal of Scleroderma and Related Disorders · 2026-06-05

OC.02 Risk factors and trajectories of interstitial lung disease in patients with limited cutaneous systemic sclerosis in the EUSTAR cohort

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.2

Journal of Scleroderma and Related Disorders · 2026-06-05

P.120 Outcomes of upfront combination vs monotherapy with rituximab or mycophenolate mofetil for systemic sclerosis interstitial lung disease (SSc-ILD): results from an EUSTAR cohort study

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.170

Journal of Scleroderma and Related Disorders · 2026-06-05

P.117 Vasodilation with prostanoids influences progression systemic sclerosis-associated interstitial lung disease: a EUSTAR cohort study

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.167

Journal of Scleroderma and Related Disorders · 2026-06-05

P.123 Ancillary HRCT features at baseline predict progressive pulmonary fibrosis in systemic sclerosis-associated interstitial lung disease: a retrospective cohort study

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.173

Journal of Scleroderma and Related Disorders · 2026-06-05

P.102 Association of interstitial lung disease (ILD) with markers of microvascular damage and fibrogenesis in systemic sclerosis (SSc

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.152

Journal of Scleroderma and Related Disorders · 2026-06-05

P.082 Serum proteins reflecting vascular processes associate with interstitial lung disease development in patients with systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.133

RMD Open · 2026-05-21

Serum KL-6 and lung ultrasound B-lines: a combined non-invasive model for screening and predicting interstitial lung disease in idiopathic inflammatory myopathy

Phrase rank #1 · DOI 10.1136/rmdopen-2026-006708

RMD Open · 2026-05-18

Validation of screening criteria for interstitial lung disease in rheumatoid arthritis in routine clinical practice: the VAR-EPIDSER study

Phrase rank #1 · DOI 10.1136/rmdopen-2026-006934

Thorax · 2026-05-11

Prevalence and outcomes of anxiety and depression in fibrotic interstitial lung disease: a registry-based analysis

Phrase rank #1 · DOI 10.1136/thorax-2026-225085

RMD Open · 2026-05-07

Nerandomilast alleviates myositis-associated interstitial lung disease by modulating the non-Smad signalling pathway and activating the cAMP–PKA–RhoA pathway

Phrase rank #1 · DOI 10.1136/rmdopen-2025-006683

BMJ Open · 2026-04-07

Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational study

Phrase rank #1 · DOI 10.1136/bmjopen-2025-114632

Thorax · 2026-04-03

Treatable traits in interstitial lung disease: towards precision medicine

Phrase rank #1 · DOI 10.1136/thorax-2024-222058